ALKERMES | ALKS - 股本和储备

金融业

USD

USD 4.26B

现金及等价物

USD 351.55M

USD 73.25M

USD 1.36B

USD 599.5M

USD 1.58B

股息收益率

0

USD -48.28M

USD 80.26M

1.8K

EPS每股收益

USD -0.4

股本和储备

USD 1.75B

USD 331.33M

债务利息支出

USD 20.89M

USD 8.54M

USD 1.48B

USD 7.18B

USD -66.48M

USD 1.75B

USD -48.28M

普通股股本

USD 166.46M

39.33

USD -61.93M

USD 392.91M

销售和管理费用

USD 264.59M

USD 336.7M

贸易债权人

USD 102.36M

应收帐款人

USD 407.63M

	股本和储备	更改		日
AbbVie	USD -6.66B		3.39B	2026-03
Acadia Pharmaceuticals	USD 1.25B		20.68M	2026-03
ALKERMES	USD 1.75B		67.76M	2026-03
Amgen	USD 9.19B		532M	2026-03
Biogen	USD 18.65B		394.9M	2026-03
BioMarin Pharmaceutical	USD 6.21B		125.11M	2026-03
Bristol-Myers Squibb	USD 20.07B		1.6B	2026-03
Coherus Biosciences	USD 61.01M		26.76M	2025-12
Eli Lilly	USD 31.2B		4.66B	2026-03
Gilead Sciences	USD 23.52B		897M	2026-03
Heron Therapeutics	USD 9.14M		4.15M	2026-03
Ionis Pharmaceuticals	USD 491.41M		2.32M	2026-03
J&J	USD 81.19B		358M	2026-03
Malin Corporation	EUR 193.2M		75M	2024-12
Merck	USD 45.88B		6.73B	2026-03
Minerva Neurosciences	USD -140.75M		106.17M	2025-12
Nektar Therapeutics	USD 89.83M		4.75M	2025-12
Neurocrine Biosciences	USD 3.41B		154.3M	2026-03
Otsuka Holdings	JPY 3.11T		74.63B	2026-03
Ovoca Bio	EUR 1.26M		7.41M	2025-06
Pfizer	USD 90.1B		3.63B	2026-03
Regeneron Pharmaceuticals	USD 31.42B		166.7M	2026-03
Vertex Pharmaceuticals	USD 19.36B		696.1M	2026-03